2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
127 hedge funds and large institutions have $479M invested in 2seventy bio in 2021 Q4 according to their latest regulatory filings, with 127 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
93% more call options, than puts
Call options by funds: $1.29M | Put options by funds: $668K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$73.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$65.2M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$59.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58M |
| 5 |
BlackRock
New York
|
+$50M |
Top Sellers
TSVT Hedge Fund Activity: Q4 2021 in Review
127 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q4 2021, worth a combined $479M.
Buyers outnumbered sellers: 127 funds opened new TSVT positions and 0 closed out — a net gain of 127 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $73.7M.
- 127 institutional investors held 2seventy bio (TSVT) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $479M of 2seventy bio stock for Q4 2021.
- 127 funds opened new 2seventy bio positions in Q4 2021 and 0 closed out, a net change of +127 holders.
- The largest 2seventy bio buyer in Q4 2021 was State Street, an estimated $73.7M added.
Based on aggregated 13F filings for Q4 2021.